These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33470814)

  • 1. Structure-Activity Relationship Study of Amidobenzimidazole Analogues Leading to Potent and Systemically Administrable Stimulator of Interferon Gene (STING) Agonists.
    Song Z; Wang X; Zhang Y; Gu W; Shen A; Ding C; Li H; Xiao R; Geng M; Xie Z; Zhang A
    J Med Chem; 2021 Feb; 64(3):1649-1669. PubMed ID: 33470814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis, and Biological Evaluation of Amidobenzimidazole Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists.
    Xi Q; Wang M; Jia W; Yang M; Hu J; Jin J; Chen X; Yin D; Wang X
    J Med Chem; 2020 Jan; 63(1):260-282. PubMed ID: 31820985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of amidobenzimidazole STING receptor agonists with systemic activity.
    Ramanjulu JM; Pesiridis GS; Yang J; Concha N; Singhaus R; Zhang SY; Tran JL; Moore P; Lehmann S; Eberl HC; Muelbaier M; Schneck JL; Clemens J; Adam M; Mehlmann J; Romano J; Morales A; Kang J; Leister L; Graybill TL; Charnley AK; Ye G; Nevins N; Behnia K; Wolf AI; Kasparcova V; Nurse K; Wang L; Puhl AC; Li Y; Klein M; Hopson CB; Guss J; Bantscheff M; Bergamini G; Reilly MA; Lian Y; Duffy KJ; Adams J; Foley KP; Gough PJ; Marquis RW; Smothers J; Hoos A; Bertin J
    Nature; 2018 Dec; 564(7736):439-443. PubMed ID: 30405246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Activity relationship study of benzothiophene oxobutanoic acid analogues leading to novel stimulator of interferon gene (STING) agonists.
    Shen A; Li X; Zhang Y; Ma J; Xiao R; Wang X; Song Z; Liu Z; Geng M; Zhang A; Xie Z; Ding C
    Eur J Med Chem; 2022 Nov; 241():114627. PubMed ID: 35963129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A next-generation STING agonist MSA-2: From mechanism to application.
    Yang J; Luo Z; Ma J; Wang Y; Cheng N
    J Control Release; 2024 Jul; 371():273-287. PubMed ID: 38789087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of BI 7446: A Potent Cyclic Dinucleotide STING Agonist with Broad-Spectrum Variant Activity for the Treatment of Cancer.
    Kuttruff CA; Fleck M; Carotta S; Arnhof H; Bretschneider T; Dahmann G; Gremel G; Grube A; Handschuh S; Heimann A; Hofmann MH; Impagnatiello MA; Nar H; Rast G; Schaaf O; Schmidt E; Oost T
    J Med Chem; 2023 Jul; 66(14):9376-9400. PubMed ID: 37450324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors.
    Francica BJ; Ghasemzadeh A; Desbien AL; Theodros D; Sivick KE; Reiner GL; Hix Glickman L; Marciscano AE; Sharabi AB; Leong ML; McWhirter SM; Dubensky TW; Pardoll DM; Drake CG
    Cancer Immunol Res; 2018 Apr; 6(4):422-433. PubMed ID: 29472271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Orally Bioavailable Amidobenzimidazole Analogues Targeting Stimulator of Interferon Gene (STING) Receptor.
    Chen NN; Zhang H; Zhu QS; Zeng T; Dai W; Zhou YL; Xin GF; Wu BD; Gong SJ; Jiang ZY; You QD; Xu XL
    J Med Chem; 2023 Apr; 66(8):5584-5610. PubMed ID: 37027512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Non-Nucleotide Small-Molecule STING Agonists
    Cherney EC; Zhang L; Lo J; Huynh T; Wei D; Ahuja V; Quesnelle C; Schieven GL; Futran A; Locke GA; Lin Z; Monereau L; Chaudhry C; Blum J; Li S; Fereshteh M; Li-Wang B; Gangwar S; Pan C; Chong C; Zhu X; Posy SL; Sack JS; Zhang P; Ruzanov M; Harner M; Akhtar F; Schroeder GM; Vite G; Fink B
    J Med Chem; 2022 Feb; 65(4):3518-3538. PubMed ID: 35108011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer flavonoids are mouse-selective STING agonists.
    Kim S; Li L; Maliga Z; Yin Q; Wu H; Mitchison TJ
    ACS Chem Biol; 2013 Jul; 8(7):1396-401. PubMed ID: 23683494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel Thieno[2,3-d]imidazole derivatives as agonists of human STING for antitumor immunotherapy using systemic administration.
    Niu J; Bai H; Li Z; Gao Y; Zhang Y; Wang X; Yang Y; Xu Y; Geng M; Xie Z; Zhou B
    Eur J Med Chem; 2022 Aug; 238():114482. PubMed ID: 35671593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E7766, a Macrocycle-Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan-Genotypic Activity.
    Kim DS; Endo A; Fang FG; Huang KC; Bao X; Choi HW; Majumder U; Shen YY; Mathieu S; Zhu X; Sanders K; Noland T; Hao MH; Chen Y; Wang JY; Yasui S; TenDyke K; Wu J; Ingersoll C; Loiacono KA; Hutz JE; Sarwar N
    ChemMedChem; 2021 Jun; 16(11):1740-1743. PubMed ID: 33522135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy.
    Wilson DR; Sen R; Sunshine JC; Pardoll DM; Green JJ; Kim YJ
    Nanomedicine; 2018 Feb; 14(2):237-246. PubMed ID: 29127039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route.
    Vyskocil S; Cardin D; Ciavarri J; Conlon J; Cullis C; England D; Gershman R; Gigstad K; Gipson K; Gould A; Greenspan P; Griffin R; Gulavita N; Harrison S; Hu Z; Hu Y; Hata A; Huang J; Huang SC; Janowick D; Jones M; Kolev V; Langston SP; Lee HM; Li G; Lok D; Ma L; Mai D; Malley J; Matsuda A; Mizutani H; Mizutani M; Molchanova N; Nunes E; Pusalkar S; Renou C; Rowland S; Sato Y; Shaw M; Shen L; Shi Z; Skene R; Soucy F; Stroud S; Xu H; Xu T; Abu-Yousif AO; Zhang J
    J Med Chem; 2021 May; 64(10):6902-6923. PubMed ID: 34000802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of potent small molecule cyclic urea activators of STING.
    Basu S; Middya S; Banerjee M; Ghosh R; Pryde DC; Yadav DB; Shrivastava R; Surya A
    Eur J Med Chem; 2022 Feb; 229():114087. PubMed ID: 34998056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational study on new natural compound agonists of stimulator of interferon genes (STING).
    Zhong S; Li W; Bai Y; Wu B; Wang X; Jiang S; Zhao Y; Ren J; Li H; Jin R
    PLoS One; 2019; 14(5):e0216678. PubMed ID: 31120925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel amidobenzimidazole derivatives as orally available small molecule modulators of stimulator of interferon genes for cancer immunotherapy.
    Jeon MJ; Lee H; Jo S; Kang M; Jeong JH; Jeong SH; Lee JY; Song GY; Choo H; Lee S; Kim H
    Eur J Med Chem; 2023 Dec; 261():115834. PubMed ID: 37862818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship study of amidobenzimidazole derivatives as stimulator of interferon genes (STING) agonists.
    Liu X; Wang M; Yang M; Sun H; Wang B; Pan X; Chen X; Jin J; Wang X
    Eur J Med Chem; 2023 Jan; 246():114943. PubMed ID: 36462438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STING Activation and its Application in Immuno-Oncology.
    Lian Y; Duffy KJ; Yang J
    Curr Top Med Chem; 2019; 19(24):2205-2227. PubMed ID: 31642767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 inhibition enhances CDN-induced STING signaling and antitumor immunity.
    Pei J; Zhang Y; Luo Q; Zheng W; Li W; Zeng X; Li Q; Quan J
    Cancer Lett; 2019 May; 450():110-122. PubMed ID: 30790684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.